Overall survival (OS) in refractory metastatic colorectal cancer (mCRC) improved significantly with the addition of the VEGF ...

The U.S. Food and Drug Administration (FDA) has granted traditional approval to Braftovi (encorafenib) for adult patients ...

Emerging CRC diagnostic tools along with better public awareness could help reverse rising deaths in younger adults, says Jordan Karlitz, MD.

SOUTH SAN FRANCISCO, Calif.-- (BUSINESS WIRE)--February 24, 2026-- ...

Adagene (NASDAQ:ADAG) highlighted updated details around its lead immuno-oncology program, ADG126, during an Oppenheimer ...

Traditional approval of encorafenib plus cetuximab and fluorouracil-based chemotherapy for patients with BRAF-mutated ...

The increase in CRC-related mortality in younger adults is driven by screening delays and advanced-stage diagnoses, according to Jordan Karlitz, MD.

A new study using one of the world's largest cancer registries shows that patient outcomes can be significantly impacted depending on when colorectal cancer (CRC) is diagnosed related to other cancers ...

Newly available noninvasive colorectal cancer tests have opened the doors to an uptick in screening, especially the first FDA-approved blood test. However, experts are unsure whether these will be as ...

As Colorectal Cancer Awareness Month begins, Colorectal Cancer Canada (CCC) is calling on provincial and territorial governments to commit to lowering the routine colorectal cancer screening age to 45 ...

Fight Colorectal Cancer (Fight CRC) and the Cancer Research Institute (CRI), are proud to announce "A Blueprint to Advance Colorectal Cancer Immunotherapies" will be published in the November 2017 ...

Researchers conducted a literature review to better understand challenges faced by LGB patients with CRC after surgical ...